-
EP2334336
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2334336
| EP2334336 - POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 18.04.2014 Database last updated on 26.07.2024 | Most recent event Tooltip | 18.04.2014 | Application deemed to be withdrawn | published on 21.05.2014 [2014/21] | Applicant(s) | For all designated states Nektar Therapeutics 455 Mission Bay Boulevard South, Suite 100 San Francisco, CA 94185 / US | [2011/25] | Inventor(s) | 01 /
ROCZNIAK, Steven O. 678 Emerald Hill Road Redwood City California 94061 / US | 02 /
ALI, Cherie F. 315 Howard Avenue Burlingame California 94010 / US | [2011/25] | Representative(s) | Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | [N/P] |
| Former [2014/02] | Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road London WC1X 8BT / GB | ||
| Former [2011/25] | Baldock, Sharon Claire Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road London WC1X 8BT / GB | Application number, filing date | 09789332.5 | 17.09.2009 | [2011/25] | WO2009US05207 | Priority number, date | US20080192672P | 19.09.2008 Original published format: US 192672 P | US20090208089P | 18.02.2009 Original published format: US 208089 P | US20090153960P | 19.02.2009 Original published format: US 153960 P | [2011/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010033218 | Date: | 25.03.2010 | Language: | EN | [2010/12] | Type: | A1 Application with search report | No.: | EP2334336 | Date: | 22.06.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.03.2010 takes the place of the publication of the European patent application. | [2011/25] | Search report(s) | International search report - published on: | EP | 25.03.2010 | Classification | IPC: | A61K47/48, C07K14/575 | [2011/25] | CPC: |
A61K47/60 (EP,US);
A61P3/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/25] | Extension states | AL | 25.03.2011 | BA | 25.03.2011 | RS | 25.03.2011 | Title | German: | POLYMERKONJUGATE VON OSTEOCALCIN-PEPTIDEN | [2011/25] | English: | POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES | [2011/25] | French: | CONJUGUÉS POLYMÈRES DE PEPTIDES D OSTÉOCALCINE | [2011/25] | Entry into regional phase | 25.03.2011 | National basic fee paid | 25.03.2011 | Designation fee(s) paid | 25.03.2011 | Examination fee paid | Examination procedure | 25.03.2011 | Amendment by applicant (claims and/or description) | 25.03.2011 | Examination requested [2011/25] | 05.09.2012 | Despatch of a communication from the examining division (Time limit: M04) | 08.01.2013 | Reply to a communication from the examining division | 19.07.2013 | Despatch of a communication from the examining division (Time limit: M04) | 30.11.2013 | Application deemed to be withdrawn, date of legal effect [2014/21] | 08.01.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/21] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 05.09.2012 | Fees paid | Renewal fee | 08.09.2011 | Renewal fee patent year 03 | 26.09.2012 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.09.2013 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Rights in Rem or Legal Means of Execution | ID: | 01 | For: | all designated states | Date: | 15.04.2013 | [2013/31] | Cited in | International search | [X]US2002028189 (JO SEONGBONG [US], et al) [X] 1,22,25-28 * paragraph [0047]; claims 13,14 *; | [Y]WO2006110776 (NEKTAR THERAPEUTICS AL CORP [US], et al) [Y] 17-19* tables 1-3 *; | [XYI]WO2008088401 (UNIV COLUMBIA [US], et al) [X] 1,4-9,20-21,26-28 * paragraph [00249] * [Y] 17-19 [I] 2-3,10-16,22-25; | [Y] - FERRON MATHIEU ET AL, "Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1 APR 2008, (20080401), vol. 105, no. 13, ISSN 1091-6490, pages 5266 - 5270, XP002559551 [Y] 1-28 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.0711119105 | [Y] - ROBERTS M J ET AL, "Chemistry for peptide and protein PEGylation", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, (20020617), vol. 54, no. 4, ISSN 0169-409X, pages 459 - 476, XP002293146 [Y] 1-28 * the whole document * DOI: http://dx.doi.org/10.1016/S0169-409X(02)00022-4 | Examination | US2006293499 |